(ECL) Ecolab - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2788651006
ECL: Cleaning, Sanitizing, Water Treatment, Infection Prevention, Pest Control
Ecolab Inc. (NYSE:ECL) delivers innovative water, hygiene, and infection prevention solutions globally, addressing critical public health needs. The company operates through four specialized segments: Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination. Each segment targets distinct industries with tailored solutions.
The Global Industrial segment provides advanced water treatment and process optimization solutions for industries such as manufacturing, food and beverage, transportation, and energy. Its offerings enhance operational efficiency and sustainability. The Global Institutional & Specialty segment serves the foodservice, hospitality, and retail sectors with cleaning and sanitizing products designed to maintain high standards of hygiene and customer satisfaction.
The Global Healthcare & Life Sciences segment focuses on infection prevention and contamination control for healthcare and pharmaceutical industries, offering comprehensive solutions under brands like Bioquell and Anios. The Global Pest Elimination segment provides pest control services to commercial establishments, ensuring safety and regulatory compliance. Ecolabs products are distributed through a network of field sales teams, distributors, and dealers.
Ecolab Inc., established in 1923 and headquartered in Saint Paul, Minnesota, is a leader in sustainability and innovation, with a strong commitment to research and development. The companys digital solutions and data analytics further enhance its value proposition, positioning it as a key player in water and hygiene management globally.
Additional Sources for ECL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ECL Stock Overview
| Market Cap in USD | 67,978m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Specialty Chemicals |
| IPO / Inception | 1988-01-05 |
ECL Stock Ratings
| Growth Rating | 32.0 |
| Fundamental | 71.7 |
| Dividend Rating | 53.9 |
| Rel. Strength | 18.7 |
| Analysts | 3.78/5 |
| Fair Price Momentum | 236.65 USD |
| Fair Price DCF | 119.16 USD |
ECL Dividends
| Dividend Yield 12m | 0.98% |
| Yield on Cost 5y | 1.34% |
| Annual Growth 5y | 4.54% |
| Payout Consistency | 96.7% |
ECL Growth Ratios
| Growth Correlation 3m | -54.9% |
| Growth Correlation 12m | 44.9% |
| Growth Correlation 5y | 32.7% |
| CAGR 5y | 6.83% |
| CAGR/Max DD 5y | 0.16 |
| Sharpe Ratio 12m | 1.62 |
| Alpha | 3.78 |
| Beta | 0.613 |
| Volatility | 28.76% |
| Current Volume | 1770.5k |
| Average Volume 20d | 1636.2k |
As of May 02, 2025, the stock is trading at USD 252.62 with a total of 1,770,540 shares traded.
Over the past week, the price has changed by +5.40%, over one month by -0.65%, over three months by +1.51% and over the past year by +13.39%.
Yes, based on ValueRay Fundamental Analyses, Ecolab (NYSE:ECL) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 71.69 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ECL as of May 2025 is 236.65. This means that ECL is currently overvalued and has a potential downside of -6.32%.
Ecolab has received a consensus analysts rating of 3.78. Therefor, it is recommend to hold ECL.
- Strong Buy: 8
- Buy: 5
- Hold: 14
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ECL Ecolab will be worth about 262.7 in May 2026. The stock is currently trading at 252.62. This means that the stock has a potential upside of +3.99%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 274.9 | 8.8% |
| Analysts Target Price | 274.9 | 8.8% |
| ValueRay Target Price | 262.7 | 4% |